25-OH-vitamin D deficiency identifies poor tumor response in hepatocellular carcinoma treated with transarterial chemoembolization

ConclusionOur study suggested that 25-OHD deficiency at baseline is a prognostic indicator for a poor tumor response in hepatocellular carcinoma treated with TACE.

Source: Clinical and Translational Oncology - June 9, 2019 Category: Cancer & Oncology Source Type: research